Corporate ActionJun 23, 2026, 05:07 PM
20/20 Biolabs Seeks Share Increase to 500M, New Equity Plan
AI Summary
20/20 Biolabs, Inc. announced its 2026 Annual Meeting of Stockholders to be held virtually on August 18, 2026. Key proposals include increasing the authorized common stock from 50 million to 500 million shares to provide flexibility for future issuances, and the approval of a new 2026 Equity Incentive Plan. Stockholders will also vote on the election of six director nominees and the ratification of the company's independent auditor.
Key Highlights
- Annual Meeting of Stockholders scheduled for August 18, 2026, to vote on five proposals.
- Proposal to increase authorized common stock from 50 million to 500 million shares.
- Proposal to approve the 2026 Equity Incentive Plan.
- Election of six director nominees to the board of directors.
- Ratification of dbbmckennon as the independent registered public accounting firm for 2026.
Price Impact
More from AIDX